THERAPEUTIC CLASS
New therapeutic strategies in systemic lupus erythematosus management
The current treatment approach for systemic lupus erythematosus (SLE), as outlined in the recommendations by international medical associations including EUL AR and the ACR , is mostly eminence- based rather than evidence- based. However, knowledge on SLE is growing quickly , and such new advances need to be translated into clinical practice. Questions remain
regarding the choice and timing of drug administration and tapering until withdrawal, which both can affect the balance between the control of disease activity and damage to organs triggered by long- standing and/or disproportionate immunosuppression
No other version available